Cheng Li et al. found that miR-125a-3p exerts direct targeting effects on hTERT in breast cancer cells, along with CYP4Z1 and the pseudogene CYP4Z2P [64, 65]. The gene discussed is CYP4Z1; the disease is breast carcinoma.